FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

M Hatanaka

Research Profile

Chemicals & Drugs

Living Beings

Physiology

Procedures

Transplantation, Heterologous

Anatomy

Co-author Network

Publications

TOP 3
N A Begum; Y Murakami; Shoki Mikata; M Matsumoto; M Hatanaka; S Nagasawa; T Kinoshita; Tsukasa Seya
Molecular remodelling of human CD46 for xenotransplantation: designing a potent complement regulator without measles virus receptor activity.
Shoki Mikata; S Miyagawa; Aya Fukui; Y Murakami; R Shirakura; H Matsuda; M Hatanaka; Misako Matsumoto; Tsukasa Seya; K Suzuki; S Nagasawa
A monomeric human C4b-binding protein (C4bp) more efficiently inactivates C3b than natural C4bp: participation of C-terminal domains in factor I-cofactor activity.
T Hara; Y Suzuki; T Nakazawa; H Nishimura; S Nagasawa; M Nishiguchi; M Matsumoto; M Hatanaka; M Kitamura; Tsukasa Seya
Post-translational modification and intracellular localization of a splice product of CD46 cloned from human testis: role of the intracellular domains in O-glycosylation.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of M Hatanaka (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2000: N A Begum; Y Murakami; Shoki Mikata; M Matsumoto; M Hatanaka; S Nagasawa; T Kinoshita; Tsukasa Seya
Molecular remodelling of human CD46 for xenotransplantation: designing a potent complement regulator without measles virus receptor activity.
Immunology 2000;100(1):131-9.
1998: Shoki Mikata; S Miyagawa; Aya Fukui; Y Murakami; R Shirakura; H Matsuda; M Hatanaka; Misako Matsumoto; Tsukasa Seya; K Suzuki; S Nagasawa
A monomeric human C4b-binding protein (C4bp) more efficiently inactivates C3b than natural C4bp: participation of C-terminal domains in factor I-cofactor activity.
Molecular immunology 1998;35(9):537-44.
1998: T Hara; Y Suzuki; T Nakazawa; H Nishimura; S Nagasawa; M Nishiguchi; M Matsumoto; M Hatanaka; M Kitamura; Tsukasa Seya
Post-translational modification and intracellular localization of a splice product of CD46 cloned from human testis: role of the intracellular domains in O-glycosylation.
Immunology 1998;93(4):546-55.
1998: Shoki Mikata; S Miyagawa; K Iwata; S Nagasawa; M Hatanaka; M Matsumoto; Wataru Kamiike; H Matsuda; R Shirakura; Tsukasa Seya
Regulation of complement-mediated swine endothelial cell lysis by a surface-bound form of human C4b binding protein.
Transplantation 1998;65(3):363-8.
1997: Tsukasa Seya; M Kurita; K Iwata; Y Yanagi; K Tanaka; K Shida; M Hatanaka; M Matsumoto; S Jun; A Hirano; S Ueda; S Nagasawa
The CD46 transmembrane domain is required for efficient formation of measles-virus-mediated syncytium.
The Biochemical journal 1997;322 ( Pt 1)():135-44.
1996: Shuji Miyagawa; Shoki Mikata; Ryota Shirakura; H Matsuda; S Nagasawa; A Terados; M Hatanaka; M Matsumoto; Tsukasa Seya
C5b-8 step lysis of swine endothelial cells by human complement and functional feature of transfected CD59.
Scandinavian journal of immunology 1996;43(4):361-6.
1996: Shuji Miyagawa; Ryota Shirakura; Shoki Mikata; Masahiro Tanemura; Norihide Fukushima; H Matsuda; A Terado; M Hatanaka; M Matsumoto; Tsukasa Seya
Functional feature of C5b-8-step lysis of swine endothelial cell- transfected CD59.
Transplantation proceedings 1996;28(2):597-8.
1995: T Hara; Y Suzuki; T Semba; M Hatanaka; M Matsumoto; Tsukasa Seya
High expression of membrane cofactor protein of complement (CD46) in human leukaemia cell lines: implication of an alternatively spliced form containing the STA domain in CD46 up-regulation.
Scandinavian journal of immunology 1995;42(6):581-90.
1995: Tsukasa Seya; T Hara; K Iwata; S Kuriyama; T Hasegawa; Y Nagase; Shuji Miyagawa; M Matsumoto; M Hatanaka; J P Atkinson
Purification and functional properties of soluble forms of membrane cofactor protein (CD46) of complement: identification of forms increased in cancer patients' sera.
International immunology 1995;7(5):727-36.
1995: Tsukasa Seya; M Kurita; T Hara; K Iwata; T Semba; M Hatanaka; M Matsumoto; Y Yanagi; S Ueda; S Nagasawa
Blocking measles virus infection with a recombinant soluble form of, or monoclonal antibodies against, membrane cofactor protein of complement (CD46).
Immunology 1995;84(4):619-25.
1995: Shuji Miyagawa; Ryota Shirakura; S Nakata; Hironori Izutani; H Matsuda; K Iwata; S Nagasawa; A Terado; M Hatanaka; M Matsumoto
Effect of transfected MACIF (CD59) on complement-mediated swine endothelial cell lysis, compared with those of membrane cofactor protein (CD46) and decay-accelerating factor (CD55).
Transplantation proceedings 1995;27(1):328-9.
1994: Shuji Miyagawa; Ryota Shirakura; G Matsumiya; S Nakata; H Matsuda; M Hatanaka; M Matsumoto; Tsukasa Seya
Possibility of prevention of hyperacute rejection by DAF and CD59 in xenotransplantation.
Transplantation proceedings 1994;26(3):1235-8.
1993: Tsukasa Seya; H Tejima; H Fukuda; T Hara; M Matsumoto; M Hatanaka; Y Sugita; T Masaoka
Acute promyelocytic leukemia with CD59 deficiency.
Leukemia research 1993;17(10):895-6.
1993: T Hara; M Matsumoto; Y Fukumori; Shuji Miyagawa; M Hatanaka; T Kinoshita; Tsukasa Seya; H Akedo
A monoclonal antibody against human decay-accelerating factor (DAF, CD55), D17, which lacks reactivity with semen-DAF.
Immunology letters 1993;37(2-3):145-52.
1993: Shuji Miyagawa; Ryota Shirakura; G Matsumiya; S Nakata; H Matsuda; M Hatanaka; M Matsumoto; H Kitamura; Tsukasa Seya
Test for ability of decay-accelerating factor (DAF, CD55) and CD59 to alleviate complement-mediated damage of xeno-erythrocytes.
Scandinavian journal of immunology 1993;38(1):37-44.